MGMT gene promoter methylation in pediatric glioblastomas

Child's Nervous System

Volumn 26, Issue 11, 2010, Pages 1613-1618

  Srivastava, Arti ^a   Jain, Ayushi ^a   Jha, Prerana ^a   Suri, Vaishali ^a   Sharma, Mehar Chand ^a   Mallick, Supriya ^a   Puri, Tarun ^a   Gupta, Deepak Kumar ^a   Gupta, Aditya ^a   Sarkar, Chitra ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Glioblastoma multiforme; MGMT methylation; P53; Pediatric tumor

Indexed keywords

METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROTEIN P53; TEMOZOLOMIDE;

ADOLESCENT; ARTICLE; CANCER RADIOTHERAPY; CHILD; CLINICAL ARTICLE; DNA METHYLATION; DOSIMETRY; FEMALE; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SCHOOL CHILD;

ADOLESCENT; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; DACARBAZINE; DNA METHYLATION; DNA MODIFICATION METHYLASES; DNA REPAIR ENZYMES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; IMMUNOENZYME TECHNIQUES; INFANT; MALE; POLYMERASE CHAIN REACTION; PROGNOSIS; PROMOTER REGIONS, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 78649326720     PISSN: 02567040     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00381-010-1214-y     Document Type: Article

References (41)

1. HS Nicholson CS Kretschmar M Krailo, et al. 2007 Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors Cancer 110 1542 1549 1:CAS:528:DC%2BD2sXhtFyqtrbF 10.1002/cncr.22961 17705175
2. DD Armstrong F Giangaspero 2003 Pediatric brain tumors: introduction Brain Pathol 13 373 375 10.1111/j.1750-3639.2003.tb00036.x 12946026
3. WA Bleyer 1999 Epidemiological impact of children with brain tumors Childs Nerv Syst 15 758 763 1:STN:280:DC%2BD3c%2FmvFantw%3D%3D 10.1007/s003810050467 10603019
4. Y Cheng HK Ng SF Zhang, et al. 1999 Genetic alterations in pediatric high-grade astrocytomas Hum Pathol 30 1284 1290 1:CAS:528:DyaK1MXnvVGntbY%3D 10.1016/S0046-8177(99)90057-6 10571506
5. PM Ganigi V Santosh B Anandh BA Chandramouli 2005 Expression of p53, EGFR, pRb and bcl-2 protein in pediatric glioblastoma multiforme: a study of 54 patients Pediatr Neurosurg 41 292 299 1:STN:280:DC%2BD2MnhsFKhtA%3D%3D 10.1159/000088731 16293948
6. V Suri P Das A Jain, et al. 2009 Pediatric glioblastomas: a histopathological and molecular genetic study Neuro Oncol 11 274 280 10.1215/15228517-2008-092 18981259
7. AM Donson SO Addo-Yobo MH Handler L Gore NK Foreman 2007 MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastomas Pediatr Blood Cancer 48 403 407 10.1002/pbc.20803 16609952
8. R Stupp WP Mason MJ van den Bent, et al. 2005 Radiotherapy plus concomitant and adjuvant temozolomide for newly diagnosed glioblastoma N Engl J Med 352 987 996 1:CAS:528:DC%2BD2MXit1Wksbk%3D 10.1056/NEJMoa043330 15758009
9. WK Yung RE Albright J Olsen 2000 A phase II study of temozolomide versus procarbazine in patients with glioblastoma multiforme at first relapse Br J Cancer 85 588 593 10.1054/bjoc.2000.1316
10. M Brada K Hoang-Xuan R Rampling, et al. 2001 Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse Ann Oncol 12 259 266 1:STN:280:DC%2BD3M3gvFamtg%3D%3D 10.1023/A:1008382516636 11300335
11. MR Gilbert HS Friedman JF Kuttesch, et al. 2002 A phase II study of temozolomide in patients with newly diagnosed supratentorial malignant glioma before radiation therapy Neuro Oncol 4 261 267 1:CAS:528:DC%2BD38XotVSmt7Y%3D 12356356
12. LC Erickson G Laurent NA Sharkey KW Kohn 1980 DNA cross-linking and monoadduct repair in nitrosourea-treated human tumour cells Nature 288 727 729 1:CAS:528:DyaL3MXhtlajsbc%3D 10.1038/288727a0 7005689
13. DB Ludlum 1990 DNA alkylation by the haloethylnitrosoureas: nature of modifications produced and their enzymatic repair or removal Mutat Res 233 117 126 1:CAS:528:DyaK3MXhvFSjtw%3D%3D 2233793
14. AE Pegg ME Dolan RC Moschel 1995 Structure, function, and inhibition of O6-alkylguanine-DNA alkyltransferase Prog Nucleic Acid Res Mol Biol 51 167 223 1:CAS:528:DyaK2MXos1ertL0%3D 10.1016/S0079-6603(08)60879-X 7659775
15. XC Qian TP Brent 1997 Methylation hot spots in the 5 flanking region denote silencing of the O6-methylguanine-DNA methyltransferase gene Cancer Res 57 3672 3677 1:CAS:528:DyaK2sXlvFentro%3D 9288770
16. M Esteller SR Hamilton PC Burger SB Baylin JG Herman 1999 Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia Cancer Res 59 793 797 1:CAS:528:DyaK1MXht1Sjurk%3D 10029064
17. M Brell A Tortosa E Verger, et al. 2005 Prognostic significance of O6-methylguanine-DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomas Clin Cancer Res 11 5167 5174 1:CAS:528:DC%2BD2MXmt12qtbg%3D 10.1158/1078-0432.CCR-05-0230 16033832
18. ME Hegi AC Diserens T Gorlia, et al. 2005 MGMT gene silencing and benefit from temozolomide in glioblastoma N Engl J Med 52 997 1003 10.1056/NEJMoa043331
19. M Esteller J Gracia-Foncillas E Andion, et al. 2000 Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents N Engl J Med 343 1350 1354 1:CAS:528:DC%2BD3cXosFOltLg%3D 10.1056/ NEJM200011093431901 11070098
20. M Eoli F Menghi MG Bruzzone, et al. 2007 Methylation of O6-methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survival Clin Cancer Res 13 2606 2613 1:CAS:528:DC%2BD2sXkslOhtb4%3D 10.1158/1078-0432.CCR-06- 2184 17473190
21. HS Friedman RE McLendon T Kerby, et al. 1998 DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma J Clin Oncol 16 3851 3857 1:CAS:528:DyaK1MXos1Si 9850030
22. 6 methyl guanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide Clin Cancer Res 10 1871 1874 1:CAS:528:DC%2BD2cXisVGltbY%3D 10.1158/1078-0432.CCR-03- 0384 15041700
23. Kleihues P, Burger PC, Aldape KD, Brat DJ, Biernat W, Bigner DD (2007) Glioblastoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) WHO classification of tumors of central nervous system, 4th edn. IARC, Lyon, pp 33-49
24. MF Paz R Yaya-Tur I Rojas-Marcos, et al. 2004 CpG island hypermethylation of the DNA repair enzyme methyltransferase predicts response to temozolomide in primary gliomas Clin Cancer Res 10 4933 4938 1:CAS:528:DC%2BD2cXmtlSisbc%3D 10.1158/1078-0432.CCR-04-0392 15297393
25. A Broniscer L Iacono M Chintagumpala, et al. 2005 Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children: results of a multiinstitutional study (SJHG-98) Cancer 103 133 139 1:CAS:528:DC%2BD2MXmtVartw%3D%3D 10.1002/cncr.20741 15565574
26. A Broniscer M Chintagumpala M Fouladi, et al. 2006 Temozolomide after radiotherapy for newly diagnosed high-grade glioma and unfavorable low-grade glioma in children J Neurooncol 76 313 319 10.1007/s11060-005-7409-5 16200343
27. AC Verschuur J Grill A Lelouch-Tubiana D Couanet C Kalifa G Vassal 2004 Temozolomide in paediatric high-grade glioma: a key for combination therapy? Br J Cancer 91 425 429 1:CAS:528:DC%2BD2cXlvF2ltrw%3D 10.1038/sj.bjc.6601997 15266331
28. G Barone P Maurizi G Tamburrini R Riccardi 2006 Role of temozolomide in pediatric brain tumors Childs Nerv Syst 22 652 661 10.1007/s00381-006-0081-z 16565851
29. RI Jakacki A Yates SM Blaney, et al. 2008 A phase I trial of temozolomide and lomustine in newly diagnosed high-grade gliomas of childhood Neuro Oncol 10 569 576 1:CAS:528:DC%2BD1cXhtVymsrbJ 10.1215/15228517-2008-019 18497327
30. LS Lashford P Thiesse A Jouvet, et al. 2002 Temozolomide in malignant gliomas of childhood: a United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup study J Clin Oncol 20 4684 4691 1:CAS:528:DC%2BD38XptlGiu7k%3D 10.1200/JCO.2002.08.141 12488414
31. EJ Estlin L Lashford S Ablett, et al. 1998 Phase I study of temozolomide in paediatric patients with advanced cancer. United Kingdom Children's Cancer Study Group Br J Cancer 78 652 661 1:CAS:528:DyaK1cXlvVCgs7k%3D 9744506
32. KC Loh J Willert H Meltzer, et al. 2005 Temozolomide and radiation for aggressive pediatric central nervous system malignancies J Pediatr Hematol Oncol 27 254 258 10.1097/01.mph.0000162528.79186.fe 15891559
33. M Belanich M Pastor T Randall, et al. 1996 Retrospective study of the correlation between the DNA repair protein alkyltransferase and survival of brain tumor patients treated with carmustine Cancer Res 56 783 788 1:CAS:528:DyaK28XhtVClsLc%3D 8631014
34. 6-alkylguanine-DNA alkyltransferase activity of human malignant glioma and its clinical implications J Neurooncol 21 135 140 1:STN:280:DyaK2M7msFWktQ%3D%3D 10.1007/BF01052897 7861189
35. D Wiewrodt G Nagel N Dreimuller T Hundsberger A Perneczky B Kaina 2008 MGMT in primary and recurrent human glioblastomas after radiation and chemotherapy and comparison with p53 status and clinical outcome Int J Cancer 122 1391 1399 1:CAS:528:DC%2BD1cXit1yht74%3D 10.1002/ijc.23219 18000822
36. 6-methylguanine- DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 Cohort J Clin Oncol 24 3431 3437 1:CAS:528:DC%2BD28Xot1KisLo%3D 10.1200/JCO.2006.05.7265 16849758
37. R Stupp ME Hegi 2007 Methylguanine methyltransferase testing in glioblastoma: when and how? J Clin Oncol 25 1459 1460 10.1200/JCO.2006.09.7139 17442986
38. S Everhard G Kaloshi E Crinière, et al. 2006 MGMT methylation: a marker of response to temozolomide in low-grade gliomas Ann Neurol 60 740 743 1:CAS:528:DC%2BD2sXhsFeqtb8%3D 10.1002/ana.21044 17192931
39. U Sure D Ruedi O Tachibana, et al. 1997 Determination of p53 mutation, EGFR overexpression and loss of p16 expression in pediatric glioblastomas J Neuropathol Exp Neurol 56 782 789 1:CAS:528:DyaK2sXkslaisr0%3D 9210874
40. MB Bhattacharjee JM Bruner 1997 p53 protein in pediatric malignant astrocytoma. A study of 21 patients J Neurooncol 32 225 233 1:STN:280: DyaK2s3gt1emtQ%3D%3D 10.1023/A:1005727902387 9049884
41. IF Pollack SD Finkelstein J Woods, et al. 2002 Expression of p53 and prognosis in children with malignant gliomas N Engl J Med 346 420 427 1:CAS:528:DC%2BD38XhtVWqu78%3D 10.1056/NEJMoa012224 11832530